Position in ABVX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$99,212
-$32,136 QoQ
Shares Held
891
-8.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Covestor Ltd holds $3,313,348 across 163 Biotechnology names. ABVX ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRTA |
Prothena Corp Public Ltd Co
|
32,657 | $317,426 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
2,840 | $276,190 | |
| 3 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
8,219 | $203,502 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
303 | $135,301 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
2,073 | $117,103 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
133 | $102,761 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,376 | $102,181 | |
| 8 | ABVX |
Abivax S.A.
This page
|
891 | $99,212 |
All Filings in ABVX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $99,212 | 891 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $131,348 | 974 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $96,446 | 1,136 | Shares | Sole | 2025-10-30 | |
| 2025-03-31 | $16,625 | 2,660 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||